Allantoicase Antikörper (N-Term)
Kurzübersicht für Allantoicase Antikörper (N-Term) (ABIN632271)
Target
Alle Allantoicase (ALLC) Antikörper anzeigenReaktivität
Wirt
Klonalität
Konjugat
Applikation
-
-
Bindungsspezifität
- N-Term
-
Spezifität
- ALLC antibody was raised against the N terminal of ALLC
-
Aufreinigung
- Affinity purified
-
Immunogen
- ALLC antibody was raised using the N terminal of ALLC corresponding to a region with amino acids VIRGFDVDVSYFTGDYAPRVSIQAANLEEDKLPEIPERGTRTGAAATPEE
-
-
-
-
Applikationshinweise
-
WB: 1 µg/mL
Optimal conditions should be determined by the investigator. -
Kommentare
-
ALLC Blocking Peptide, (ABIN5612027), is also available for use as a blocking control in assays to test for specificity of this ALLC antibody
-
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Format
- Lyophilized
-
Rekonstitution
- Lyophilized powder. Add distilled water for a 1 mg/mL concentration of ALLC antibody in PBS
-
Konzentration
- Lot specific
-
Buffer
- PBS
-
Handhabung
-
Avoid repeated freeze/thaw cycles.
Dilute only prior to immediate use. -
Lagerung
- 4 °C/-20 °C
-
Informationen zur Lagerung
- Store at 2-8 °C for short periods. For longer periods of storage, store at -20 °C.
-
-
- Allantoicase (ALLC)
-
Andere Bezeichnung
- ALLC
-
Hintergrund
- Allantoicase participates in the uric acid degradation pathway. Its enzymatic activity, like that of urate oxidase, was lost during vertebrate evolution.
-
Molekulargewicht
- 43 kDa (MW of target protein)
Target
-